Table 6.
Model | Any cancer | Palpable cancer | Advanced cancer |
---|---|---|---|
All | |||
| |||
Number of cases/controls | 998/2811 | 588/1627 | 309/855 |
| |||
Total PSA | 0.722 (0.704, 0.740) | 0.735 (0.709, 0.758) | 0.759 (0.725, 0.790) |
Free PSA | 0.673 (0.655, 0.693) | 0.688 (0.663, 0.712) | 0.725 (0.690, 0.757) |
% Free PSA | 0.658 (0.641, 0.674) | 0.673 (0.650, 0.693) | 0.665 (0.634, 0.695) |
hK2 | 0.630 (0.612, 0.652) | 0.644 (0.620, 0.672) | 0.660 (0.627, 0.697) |
Combination | 0.728 (0.711, 0.746) | 0.741 (0.718, 0.764) | 0.759 (0.727, 0.791) |
| |||
Above the median (≥ 0.63 ng/ml) | |||
| |||
Number of cases/controls | 784/1366 | 465/776 | 251/413 |
| |||
Total PSA | 0.657 (0.633, 0.684) | 0.675 (0.648, 0.713) | 0.711 (0.673, 0.758) |
Free PSA | 0.590 (0.569, 0.617) | 0.609 (0.586, 0.651) | 0.661 (0.628, 0.716) |
% Free PSA | 0.618 (0.595, 0.639) | 0.636 (0.603, 0.663) | 0.630 (0.575, 0.658) |
hK2 | 0.580 (0.557, 0.608) | 0.600 (0.568, 0.637) | 0.610 (0.580, 0.666) |
Combination | 0.672 (0.650, 0.697) | 0.695 (0.667, 0.729) | 0.715 (0.680, 0.766) |
| |||
Above the top quartile (≥ 0.95 ng/ml) | |||
| |||
Number of cases/controls | 552/663 | 333/377 | 196/204 |
| |||
Total PSA | 0.618 (0.573, 0.648) | 0.653 (0.601, 0.699) | 0.671 (0.605, 0.732) |
Free PSA | 0.547 (0.510, 0.584) | 0.583 (0.532, 0.629) | 0.620 (0.560, 0.688) |
% Free PSA | 0.605 (0.562, 0.629) | 0.623 (0.581, 0.667) | 0.602 (0.547, 0.652) |
hK2 | 0.600 (0.575, 0.646) | 0.619 (0.577, 0.674) | 0.630 (0.564, 0.698) |
Combination | 0.659 (0.628, 0.695) | 0.687 (0.651, 0.745) | 0.705 (0.644, 0.769) |